SGLT2 Inhibitors and the Cardiorenal Continuum: A Paradigm Shift in the Treatment of Patients with T2D

被引：0
|
作者：
Javier Escalada
机构：
[1] Clínica Universidad de Navarra,Department of Endocrinology and Nutrition
[2] Instituto de Salud Carlos III,CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN)
来源：
Diabetes Therapy | 2022年 / 13卷
关键词：
Type 2 diabetes; SGLT2 inhibitors; Cardiorenal; Cardiovascular disease; Kidney disease; Heart failure; Morbidity; Mortality; Chronic kidney disease; Cardiorenal continuum;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1 / 3
页数：2
相关论文
共 50 条
  • [21] In HF, T2D, CKD, or atherosclerotic CVD, SGLT2 inhibitors reduce HF hospitalizations and CV mortality
    Zhu, Doreen
    Herrington, William G.
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (11)
  • [22] A PARADIGM SHIFT FOR THE SGLT2 INHIBITORS - TREATING THE HEART WITH ANTI-HYPERGLYCAEMIC DRUGS
    Badila, Elisabeta
    Balahura, Ana-Maria
    Stoian, Marilena
    Bartos, Daniela
    Vinereanu, Dragos
    FARMACIA, 2021, 69 (05) : 837 - 848
  • [23] Effects of SGLT2 Inhibition on Skeletal Muscle Bioenergetics and Myocellular Lipids in Patients with T2D and HFrEF
    Qin, Yuejuan
    Sanchez, Noah D.
    Moody, Alexander
    Acosta, Francisca M.
    Neppala, Sivaram
    Brown, Marissa
    Honka, Henri
    Moreno, Luis A. Cruz
    Triplitt, Curtis L.
    Clarke, Geoffrey D.
    Cersosimo, Eugenio
    Defronzo, Ralph A.
    Solis-Herrera, Carolina
    DIABETES, 2023, 72
  • [24] Mechanisms of action of SGLT2 inhibitors and their beneficial effects on the cardiorenal axis
    Gronda, Edoardo
    Lopaschuk, Gary D.
    Arduini, Arduino
    Santoro, Antonio
    Benincasa, Giuditta
    Palazzuoli, Alberto
    Gabrielli, Domenico
    Napoli, Claudio
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2022, 100 (02) : 93 - 106
  • [25] SGLT2 Inhibitors in Liver Patients
    Hsiang, John Chen
    Wong, Vincent Wai-Sun
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (10) : 2168 - +
  • [26] SGLT2 INHIBITORS
    Brito, M.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E162 - E162
  • [27] SGLT2 inhibitors
    Dardi, I.
    Kouvatsos, T.
    Jabbour, S. A.
    BIOCHEMICAL PHARMACOLOGY, 2016, 101 : 27 - 39
  • [28] SGLT2 inhibitors in the treatment of type 2 diabetes
    Hasan, Farhad M.
    Alsahli, Mazen
    Gerich, John E.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 104 (03) : 297 - 322
  • [29] SGLT2 inhibitors
    Steyn, Lynda
    SA PHARMACEUTICAL JOURNAL, 2018, 85 (01) : 72 - 75
  • [30] Are the antidiabetic SGLT2 inhibitors a cardiovascular treatment?
    Vargas Delgado, Ariana P.
    Requena Ibanez, Juan Antonio
    Santos-Gallego, Carlos G.
    Jose Badimon, Juan
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2021, 33 (01): : 33 - 40
12345